Dashboard
With a growth in Net Sales of 8.51%, the company declared Very Positive results in Jun 25
- The company has declared positive results for the last 2 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 94.8 MM
- RAW MATERIAL COST(Y) Fallen by -12.27% (YoY)
- DEBT-EQUITY RATIO (HY) Lowest at -39.16 %
High Institutional Holdings at 100%
Stock DNA
Other Electrical Equipment
USD 4,422 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.39
-9.86%
4.17
Total Returns (Price + Dividend) 
Silicon Laboratories, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
Is Silicon Laboratories, Inc. technically bullish or bearish?
As of 28 August 2025, the technical trend for Silicon Laboratories, Inc. has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD remains bullish, indicating mixed signals across time frames. The daily moving averages are bullish, supporting a positive short-term outlook. Bollinger Bands are bullish on both weekly and monthly charts, suggesting potential upward momentum. However, the weekly KST is mildly bearish, and the Dow Theory shows a mildly bearish stance on the weekly timeframe with no trend on the monthly. In terms of performance, Silicon Laboratories has outperformed the S&P 500 over the past week (4.26% vs. 1.05%) and the past month (6.80% vs. 2.33%), but has lagged significantly over the longer-term periods, particularly in the 3-year (9.13% vs. 70.41%) and 5-year (46.92% vs. 96.61%) comparisons. Overall, the current technical stance is mildly bullish...
Read MoreIs Silicon Laboratories, Inc. overvalued or undervalued?
As of 7 February 2024, Silicon Laboratories, Inc. has moved from a fair to risky valuation grade, indicating a shift towards being overvalued. The company appears overvalued given its negative P/E ratio and poor returns on capital, with a Price to Book Value of 3.86 and an EV to Sales ratio of 5.64, which are significantly higher than peers like Fabrinet, which has a P/E of 41.84, and Qorvo, Inc., with a P/E of 36.95. Additionally, the company’s ROCE and ROE are both negative at -21.51% and -15.44%, respectively, further supporting the overvaluation thesis. In terms of recent performance, Silicon Laboratories has outperformed the S&P 500 over the past week, month, and year, with returns of 4.26%, 6.80%, and 27.53%, respectively, compared to the S&P 500's 1.05%, 2.33%, and 17.14%. However, over longer periods such as 3 years and 5 years, the company significantly lags behind the S&P 500, with returns of 9.1...
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 98 Schemes (62.98%)
Held by 153 Foreign Institutions (15.46%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
QoQ Growth in quarter ended Jun 2025 is 8.50% vs 6.92% in Mar 2025
QoQ Growth in quarter ended Jun 2025 is 28.52% vs -28.15% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -25.30% vs -23.61% in Dec 2023
YoY Growth in year ended Dec 2024 is -453.62% vs -137.75% in Dec 2023






